SCHEMBL20199982

SCHEMBL20199982

COC(=O)CN1CCN(CC(=O)OC)CCN(CC(=O)N(CC(=O)O)Cc2ccccc2)CCN(CC(=O)OC)CC1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
POLB P06746 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.42
TSPO P30536 1/20 0.41
MRGPRX1 Q96LB2 1/20 0.41
OPRM1 P35372 1/20 0.41
SIGMAR1 Q99720 1/20 0.41
REN P00797 1/20 0.40
TACR1 P25103 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
DRD4 P21917 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39
CHRM3 P20309 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20187486 0.87 ALDH1A1 (0.49) ALDH1A1MEN1KMT2APOLBTSPO
SCHEMBL29834101 0.85 ALDH1A1 (0.48) ALDH1A1MEN1KMT2APOLBTSPO
SCHEMBL23656474 0.85 MEN1 (0.39) ALDH1A1MEN1KMT2APOLBTACR1
SCHEMBL20191192 0.82 ALDH1A1 (0.45) ALDH1A1MEN1KMT2APOLBTSPO
SCHEMBL20187483 0.81 CTSL (0.46) ALDH1A1MEN1KMT2APOLBSMN1; SMN2
SCHEMBL20199816 0.80 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2
SCHEMBL20200024 0.80 KDM4E (0.43) ALDH1A1MEN1KMT2APOLBMRGPRX1
SCHEMBL20199981 0.80 DRD4 (0.43) ALDH1A1OPRM1SIGMAR1TACR1DRD4
SCHEMBL22446610 0.79 POLB (0.42) ALDH1A1MEN1KMT2APOLBTACR1
SCHEMBL572327 0.77 ALDH1A1 (0.62) ALDH1A1MEN1KMT2ASMN1; SMN2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544964-B1 HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING Bayer Pharma AG (DE) 2020-06-17 EP disclosed
WO-2018096082-A1 HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 WO disclosed